{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T22:31:12Z","timestamp":1767652272083},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,9,3]],"date-time":"2015-09-03T00:00:00Z","timestamp":1441238400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Pediatr"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1007\/s12098-015-1859-3","type":"journal-article","created":{"date-parts":[[2015,9,2]],"date-time":"2015-09-02T01:10:20Z","timestamp":1441156220000},"page":"226-231","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Dyslipidemia in HIV Infected Children Receiving Highly Active Antiretroviral Therapy"],"prefix":"10.1007","volume":"83","author":[{"given":"Anirban","family":"Mandal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aparna","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Lakshmy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sushil K.","family":"Kabra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rakesh","family":"Lodha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,9,3]]},"reference":[{"key":"1859_CR1","doi-asserted-by":"crossref","unstructured":"Gortmaker SL, Hughes M, Cervia J, Brady M, Johnson GM, Seage GR\u00a03rd, et al. Effect of combination therapy including protease inhibitors on mortality among children and adolescents infected with HIV-1. N Engl J Med. 2001;345:1522\u20138.","DOI":"10.1056\/NEJMoa011157"},{"key":"1859_CR2","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1086\/423178","volume":"39","author":"RM Viani","year":"2004","unstructured":"Viani RM, Araneta MR, Deville JG, Spector SA. Decrease in hospitalization and mortality rates among children with perinatally acquired HIV type 1 infection receiving highly active antiretroviral therapy. Clin Infect Dis. 2004;39:725\u201331.","journal-title":"Clin Infect Dis"},{"key":"1859_CR3","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1086\/420738","volume":"38","author":"S Resino","year":"2004","unstructured":"Resino S, Bellon JM, Resino R, et al. Extensive implementation of highly active antiretroviral therapy shows great effect on survival and surrogate markers in vertically HIV-infected children. Clin Infect Dis. 2004;38:1605\u201312.","journal-title":"Clin Infect Dis"},{"key":"1859_CR4","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/00006454-200301000-00018","volume":"22","author":"EG Leonard","year":"2003","unstructured":"Leonard EG, McComsey GA. Metabolic complication of antiretroviral therapy in children. Pediatr Infect Dis J. 2003;22:77\u201384.","journal-title":"Pediatr Infect Dis J"},{"key":"1859_CR5","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1097\/00002030-200409030-00004","volume":"18","author":"GA McComsey","year":"2004","unstructured":"McComsey GA, Leonard E. Metabolic complications of HIV therapy in children. AIDS. 2004;18:1753\u201368.","journal-title":"AIDS"},{"key":"1859_CR6","doi-asserted-by":"crossref","unstructured":"Brewinski M, Megazzini K, Hance LF, et al; NISDI Pediatric Study Group 2010. Dyslipidemia in a cohort of HIV infected Latin American children receiving highly active antiretroviral therapy. J Trop Pediatr. 2010;57:324\u201332.","DOI":"10.1093\/tropej\/fmq089"},{"key":"1859_CR7","doi-asserted-by":"crossref","unstructured":"Hazraa R, Cohen RA, Gonin R, et al; NISDI Pediatric Study Group 2011. Lipid levels in the second year of life among HIV-infected and HIV-exposed uninfected Latin American children. AIDS. 2012;26:235\u201340.","DOI":"10.1097\/QAD.0b013e32834dc5fc"},{"key":"1859_CR8","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1177\/135965350701200811","volume":"12","author":"L Aurpibul","year":"2007","unstructured":"Aurpibul L, Puthanakit T, Lee B, Mangklabruks A, Sirisanthana T, Sirisanthana V. Lipodystrophy and metabolic changes in HIV infected children on non nucleoside reverse transcriptase inhibitor based antiretroviral therapy. Antivir Ther. 2007;12:1247\u201354.","journal-title":"Antivir Ther"},{"key":"1859_CR9","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s12098-009-0216-9","volume":"76","author":"A Parakh","year":"2009","unstructured":"Parakh A, Dubey AP, Kumar A, Maheshwari A. Lipodystrophy and metabolic complications of highly active antiretroviral therapy. Indian J Pediatr. 2009;76:1017\u201321.","journal-title":"Indian J Pediatr"},{"key":"1859_CR10","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1097\/01.aids.0000131334.38172.01","volume":"18","author":"European Pediatric Lipodystrophy Group","year":"2004","unstructured":"European Pediatric Lipodystrophy Group. Antiretroviral therapy, fat redistribution and hyperlipidemia in HIV-infected children in Europe. AIDS. 2004;18:1443\u201351.","journal-title":"AIDS"},{"key":"1859_CR11","unstructured":"National AIDS Control Organization (NACO). Guidelines for HIV care and treatment in infants and children. New Delhi: Ministry of Health and Family Welfare, Govt. of India; 2006."},{"key":"1859_CR12","unstructured":"WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children. Geneva: World Health Organization; 2007. Available at: www.who.int\/hiv\/pub\/guidelines\/HIVstaging150307.pdf ."},{"key":"1859_CR13","unstructured":"Dietary guidelines for Indians: a manual. 2nd ed. Hyderabad: National Institute of Nutrition, Indian Council of Medical Research; 2011."},{"key":"1859_CR14","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","volume":"18","author":"WT Friedewald","year":"1972","unstructured":"Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499\u2013502.","journal-title":"Clin Chem"},{"key":"1859_CR15","doi-asserted-by":"crossref","unstructured":"National cholesterol education programme (NCEP): highlights of the reports of the expert panel on blood cholesterol levels in children and adolescents. Pediatrics. 1992; 89:495\u2013501.","DOI":"10.1542\/peds.89.3.495"},{"key":"1859_CR16","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00431-006-0193-1","volume":"166","author":"L Ene","year":"2007","unstructured":"Ene L, Goetghebuer T, Hainaut M, Peltier A, Toppet V, Levy J. Prevalence of lipodystrophy in HIV-infected children: a cross-sectional study. Eur J Pediatr. 2007;166:13\u201321.","journal-title":"Eur J Pediatr"},{"key":"1859_CR17","unstructured":"Lapphra K, Vanprapar N, Phongsamart W, Chearskul P, Chokephaibulkit K. Dyslipidemia and lipodystrophy in HIV infected Thai children on highly active antiretroviral therapy (HAART). J Med Assoc Thai. 2005;88:956\u201366."},{"key":"1859_CR18","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1097\/00002030-200112070-00008","volume":"15","author":"M Valk van der","year":"2001","unstructured":"van der Valk M, Kastelein JJ, Murphy RL. et al; Atlantic Study Team. Nevirapine containing antiretroviral therapy in HIV-1 infected patients results in an anti-atherogenic lipid profile. AIDS. 2001;15:2407\u201314.","journal-title":"AIDS"},{"key":"1859_CR19","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1097\/00002030-200009290-00008","volume":"14","author":"D Jaquet","year":"2000","unstructured":"Jaquet D, Levine M, Ortega-Rodriguez E, et al. Clinical and metabolic presentation of the lipodystrophic syndrome in HIV-infected children. AIDS. 2000;14:2123\u20138.","journal-title":"AIDS"},{"key":"1859_CR20","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1086\/590150","volume":"47","author":"RB Effros","year":"2008","unstructured":"Effros RB, Fletcher CV, Gebo K, et al. Aging and infectious diseases: workshop on HIV infection and aging: what is known and future research directions. Clin Infect Dis. 2008;47:542\u201353.","journal-title":"Clin Infect Dis"},{"key":"1859_CR21","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMoa062744","volume":"356","author":"N Friis-M\u00f8ller","year":"2007","unstructured":"Friis-M\u00f8ller N, Reiss P, Sabin CA, et al;\u00a0DAD Study Group. Class of antiretroviral drugs and the risk of myocardial infarction. N Engl J Med. 2007;356:1723\u201335.","journal-title":"N Engl J Med"},{"key":"1859_CR22","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1097\/00002030-200305230-00010","volume":"17","author":"N Friis-M\u00f8ller","year":"2003","unstructured":"Friis-M\u00f8ller N, Weber R, Reiss P, et al; Cardiovascular disease risk factors in HIV patients-association with antiretroviral therapy. Results from the DAD study. AIDS. 2003;17:1179\u201393.","journal-title":"AIDS"},{"key":"1859_CR23","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(08)60423-7","volume":"371","author":"CA Sabin","year":"2008","unstructured":"Sabin CA, Worm SW, Weber R, et al;\u00a0DAD Study Group. Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:a:D study: a multi-cohort collaboration. Lancet. 2008;371:1417\u201326.","journal-title":"Lancet"},{"key":"1859_CR24","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1210\/jc.2006-2190","volume":"92","author":"VA Triant","year":"2007","unstructured":"Triant VA, Lee H, Hadigan C, Grinspoon SK. Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. J Clin Endocrinol Metab. 2007;92:2506\u201312.","journal-title":"J Clin Endocrinol Metab."}],"container-title":["The Indian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-015-1859-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12098-015-1859-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-015-1859-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,21]],"date-time":"2022-05-21T05:58:46Z","timestamp":1653112726000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12098-015-1859-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,3]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["1859"],"URL":"https:\/\/doi.org\/10.1007\/s12098-015-1859-3","relation":{},"ISSN":["0019-5456","0973-7693"],"issn-type":[{"value":"0019-5456","type":"print"},{"value":"0973-7693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,3]]}}}